Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Anaemia+4

Recruiting

Registered drugNo placebo

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Major depression

Recruiting

Investigational

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Lumateperone

Contact Research Centre

Chronic kidney disease+1

Recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

InvestigationalNo placebo

Bulgaria

Participants:0–17 years · 18–64 years
Substances:Finerenone

Contact Research Centre

Polycythaemia vera

Recruiting

Registered drugNo placebo

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Carbasalate Calcium

Contact Research Centre

Factor VIII deficiency

Recruiting

Registered drugNo placebo

Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

Registered drugNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Relapsing multiple sclerosis+2

Recruiting

Registered drug

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Teriflunomide

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Acp-204 Tartrate

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Mk-1084

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Balcinrenone

Contact Research Centre

Factor VIII deficiency+3

Recruiting

InvestigationalNo placebo

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

InvestigationalNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Concizumab

Contact Research Centre

Find therapies in clinical trials near you – page 12

433 trials match your criteria

Anaemia+4

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Major depression

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Chronic kidney disease+1

Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

Polycythaemia vera

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Factor VIII deficiency

Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

Relapsing multiple sclerosis+2

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Chronic lymphocytic leukaemia+1

Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Dementia Alzheimer's type

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

Non-small cell lung cancer

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Myelofibrosis+1

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Cardiac failure

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Factor VIII deficiency+3

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.